Amanote Research
Register
Sign In
PSA Levels and Prognosis in Patients With Hormone-Refractory Prostate Cancer Treated With Low-Dose Dexamethasone
Japanese Journal of Urology
- Japan
doi 10.5980/jpnjurol.92.284_3
Full Text
Open PDF
Abstract
Available in
full text
Categories
Urology
Date
January 1, 2001
Authors
Unknown
Publisher
Japanese Urological Association
Related search
Low-Dose Docetaxel in Combination With Dexamethasone for Hormone-Refractory Prostate Cancer
Japanese Journal of Urology
Urology
Effects of Intravenous Administration of High Dose-Diethylstilbestrol Diphosphate on Serum Hormonal Levels in Patients With Hormone-Refractory Prostate Cancer.
Endocrine Journal
Endocrinology
Metabolism
Diabetes
Peripheral Zone Prostate Cancer in Patients With Elevated PSA Levels and Low Free-To-Total PSA Ratio: Detection With MR Imaging and MR Spectroscopy
Radiology
Nuclear Medicine
Radiology
Imaging
Low-Dose Lenalidomide and Dexamethasone Combination Treatment in Elderly Patients With Relapsed and Refractory Multiple Myeloma
Hematology
Hematology
Hormone-Refractory Prostate Cancer
Prostate Cancer Screening With PSA: "Aequanimitas"
International braz j urol : official journal of the Brazilian Society of Urology
Medicine
Urology
Achieving Treatment Goals for Hormone-Refractory Prostate Cancer With Chemotherapy
Oncologist
Cancer Research
Medicine
Oncology
Economic Evaluation of Denosumab Compared With Zoledronic Acid in Hormone-Refractory Prostate Cancer Patients With Bone Metastases
Journal of Managed Care Pharmacy
Treatment Responses in Adult Depressive Patients Treated With Dexamethasone/Corticotrophin-Releasing Hormone
Tropical Journal of Pharmaceutical Research
Pharmacology
Pharmaceutical Science
